{
  "questionId": "MISSION-500-77-1771347734024",
  "itemType": "bowtie",
  "questionType": "standalone",
  "difficulty": 5,
  "questionText": "A 58-year-old male with a history of poorly controlled type 2 diabetes and hypertension was admitted 48 hours ago for community-acquired pneumonia. The nurse is preparing the client for a scheduled CT Angiography of the chest with IV contrast to rule out a pulmonary embolism. The nurse reviews the client's electronic health record before calling transport. Based on the provided information, identify the condition the client is most likely experiencing, two actions the nurse should take, and two parameters the nurse should monitor.",
  "exhibits": [
    {
      "exhibitId": "NursesNotes",
      "exhibitType": "NursesNotes",
      "exhibitTitle": "Nurse's Notes",
      "exhibitData": [
        {
          "noteTime": "07:30",
          "noteText": "Client reports increasing fatigue and mild shortness of breath this morning. Lungs with fine crackles noted in bilateral bases, which is new from yesterday's assessment. Denies chest pain. Alert and oriented x4. IV piperacillin-tazobactam infusing. Urine output from 23:00-07:00 was 150 mL via indwelling catheter. Provider notified of subjective complaints; order for STAT labs and ECG placed and completed. Awaiting results."
        }
      ]
    },
    {
      "exhibitId": "VitalSigns",
      "exhibitType": "VitalSigns",
      "exhibitTitle": "Vital Signs",
      "exhibitData": [
        {
          "label": "Time",
          "values": [
            "Yesterday 20:00",
            "Today 04:00",
            "Today 08:00"
          ]
        },
        {
          "label": "Temperature (°C)",
          "values": [
            "37.4",
            "37.2",
            "37.3"
          ]
        },
        {
          "label": "Heart Rate (/min)",
          "values": [
            "88",
            "92",
            "78"
          ]
        },
        {
          "label": "Blood Pressure (mmHg)",
          "values": [
            "148/86",
            "155/90",
            "160/94"
          ]
        },
        {
          "label": "Respiratory Rate (/min)",
          "values": [
            "18",
            "22",
            "26"
          ]
        },
        {
          "label": "SpO2 (%)",
          "values": [
            "95% on 2L NC",
            "94% on 2L NC",
            "92% on 2L NC"
          ]
        }
      ]
    },
    {
      "exhibitId": "LabResults",
      "exhibitType": "LabResults",
      "exhibitTitle": "Laboratory Results",
      "exhibitData": [
        {
          "lab": "Potassium",
          "unit": "mEq/L",
          "range": "3.5-5.0",
          "values": [
            {
              "timestamp": "Admission",
              "value": "4.1"
            },
            {
              "timestamp": "Today 08:15",
              "value": "6.2",
              "isCritical": true
            }
          ]
        },
        {
          "lab": "Sodium",
          "unit": "mEq/L",
          "range": "136-145",
          "values": [
            {
              "timestamp": "Admission",
              "value": "138"
            },
            {
              "timestamp": "Today 08:15",
              "value": "134"
            }
          ]
        },
        {
          "lab": "BUN",
          "unit": "mg/dL",
          "range": "10-20",
          "values": [
            {
              "timestamp": "Admission",
              "value": "24"
            },
            {
              "timestamp": "Today 08:15",
              "value": "52",
              "isCritical": true
            }
          ]
        },
        {
          "lab": "Creatinine",
          "unit": "mg/dL",
          "range": "0.6-1.2",
          "values": [
            {
              "timestamp": "Admission",
              "value": "1.4"
            },
            {
              "timestamp": "Today 08:15",
              "value": "3.1",
              "isCritical": true
            }
          ]
        },
        {
          "lab": "WBC",
          "unit": "x10³/μL",
          "range": "4.5-11.0",
          "values": [
            {
              "timestamp": "Admission",
              "value": "14.8"
            },
            {
              "timestamp": "Today 08:15",
              "value": "12.5"
            }
          ]
        }
      ]
    },
    {
      "exhibitId": "ECG",
      "exhibitType": "DiagnosticFinding",
      "exhibitTitle": "ECG Interpretation (0810)",
      "exhibitData": {
        "title": "ECG Interpretation (Today 08:10)",
        "finding": "Sinus rhythm at 78/min. PR interval 0.18 seconds. QRS complex widened to 0.14 seconds. Prominent, tall, peaked T-waves noted in leads V2-V5. No acute ST-segment elevation or depression."
      }
    },
    {
      "exhibitId": "MAR",
      "exhibitType": "MAR",
      "exhibitTitle": "Medication Administration Record",
      "exhibitData": {
        "orders": [
          "Piperacillin-tazobactam 3.375 g IV every 8 hours",
          "Lisinopril 10 mg PO daily (Held since admission)",
          "Normal Saline 0.9% IV at 75 mL/hr",
          "CT Angiography Chest with IV contrast STAT"
        ]
      }
    }
  ],
  "bowtie": {
    "prompt": "The nurse reviews the client's electronic health record before calling transport for the scheduled CT Angiography with IV contrast. Drag the tiles from the options below to fill in the diagram.",
    "condition": {
      "id": "condition",
      "label": "Potential Condition",
      "options": [
        {
          "id": "cond_1",
          "text": "Pulmonary Embolism"
        },
        {
          "id": "cond_2",
          "text": "Acute Kidney Injury with severe hyperkalemia"
        },
        {
          "id": "cond_3",
          "text": "Decompensated Heart Failure"
        },
        {
          "id": "cond_4",
          "text": "Sepsis with ARDS"
        },
        {
          "id": "cond_5",
          "text": "Anaphylactic reaction to antibiotic"
        }
      ]
    },
    "actions": {
      "id": "actions",
      "label": "Actions to Take",
      "options": [
        {
          "id": "act_1",
          "text": "Administer furosemide 40 mg IV push."
        },
        {
          "id": "act_2",
          "text": "Request a STAT chest x-ray."
        },
        {
          "id": "act_3",
          "text": "Withhold contrast media and notify the provider immediately."
        },
        {
          "id": "act_4",
          "text": "Place the client on continuous cardiac monitoring."
        },
        {
          "id": "act_5",
          "text": "Proceed with transport to CT scanner."
        }
      ]
    },
    "monitoring": {
      "id": "monitoring",
      "label": "Parameters to Monitor",
      "options": [
        {
          "id": "mon_1",
          "text": "Urine output and specific gravity"
        },
        {
          "id": "mon_2",
          "text": "ECG morphology (QRS width, T-wave)"
        },
        {
          "id": "mon_3",
          "text": "Serum potassium level"
        },
        {
          "id": "mon_4",
          "text": "Blood urea nitrogen (BUN)"
        },
        {
          "id": "mon_5",
          "text": "Respiratory rate and oxygen saturation"
        }
      ]
    }
  },
  "answer": {
    "condition": "cond_2",
    "actions": [
      "act_3",
      "act_4"
    ],
    "monitoring": [
      "mon_2",
      "mon_3"
    ]
  },
  "answerBreakdown": {
    "condition": {
      "cond_1": {
        "isCorrect": false,
        "rationale": "Incorrect. While a pulmonary embolism (PE) is the reason for the ordered CT angiography, the client's most acute and life-threatening problem is the severe hyperkalemia and acute kidney injury (AKI). The elevated potassium (6.2 mEq/L), BUN (52 mg/dL), and creatinine (3.1 mg/dL), along with ECG changes (peaked T-waves, widened QRS), indicate a critical metabolic imbalance requiring immediate intervention. PE is a consideration, but not the priority."
      },
      "cond_2": {
        "isCorrect": true,
        "rationale": "Correct. The client's laboratory results reveal a significant increase in BUN and creatinine levels, indicating AKI. The elevated potassium level of 6.2 mEq/L, coupled with ECG changes such as peaked T-waves and a widened QRS complex, confirms severe hyperkalemia. Hyperkalemia disrupts the normal resting membrane potential of cardiac cells, leading to increased excitability and potentially fatal arrhythmias such as ventricular fibrillation or asystole. The kidneys' inability to excrete potassium, exacerbated by factors like diabetes and possibly certain medications, contributes to this dangerous electrolyte imbalance. This combination of AKI and hyperkalemia represents the most immediate threat to the client's well-being."
      },
      "cond_3": {
        "isCorrect": false,
        "rationale": "Incorrect. While the client exhibits signs of fluid overload (crackles, shortness of breath), which can occur in decompensated heart failure, the primary driver and most critical finding is the severe AKI and cardiotoxic hyperkalemia. The cardiac issues are secondary to the metabolic derangement. Decompensated heart failure would typically present with additional signs such as jugular venous distension, edema, and possibly an S3 heart sound, which are not mentioned in the scenario."
      },
      "cond_4": {
        "isCorrect": false,
        "rationale": "Incorrect. Although the client was admitted for pneumonia, which can lead to sepsis, the provided data does not strongly support a diagnosis of sepsis with ARDS. While the WBC is elevated, the vital signs do not indicate septic shock (e.g., hypotension). The respiratory distress is more likely related to fluid overload secondary to AKI. The primary critical data points to a renal and electrolyte emergency."
      },
      "cond_5": {
        "isCorrect": false,
        "rationale": "Incorrect. The client is not exhibiting signs of anaphylaxis, such as urticaria, angioedema, stridor, or profound hypotension. The clinical picture is consistent with a metabolic and renal deterioration, not an acute allergic reaction."
      }
    },
    "actions": {
      "act_1": {
        "isCorrect": false,
        "rationale": "Incorrect. While furosemide, a loop diuretic, can help manage fluid overload, it is not the priority intervention in the presence of severe hyperkalemia. Furosemide promotes potassium excretion, but its effect is not immediate and may not be sufficient to address the dangerously high potassium level quickly enough. Furthermore, in the setting of AKI, the kidneys may not respond effectively to diuretics. The priority is to stabilize the cardiac membrane and shift potassium intracellularly."
      },
      "act_2": {
        "isCorrect": false,
        "rationale": "Incorrect. A chest x-ray might be useful to evaluate the crackles in the lungs, but it does not address the immediate, life-threatening cardiac instability caused by hyperkalemia. The priority actions must focus on preventing a fatal arrhythmia. While the respiratory symptoms warrant investigation, they are secondary to the electrolyte imbalance."
      },
      "act_3": {
        "isCorrect": true,
        "rationale": "Correct. This is a critical safety measure. Administering IV contrast dye, a known nephrotoxin, to a client in AKI (creatinine 3.1 mg/dL) is contraindicated and could cause further, potentially irreversible kidney damage. Contrast-induced nephropathy (CIN) occurs due to vasoconstriction and direct toxic effects on renal tubular cells. The nurse must immediately recognize this contraindication, withhold the procedure, and communicate with the provider to discuss alternative imaging options or renal protection strategies."
      },
      "act_4": {
        "isCorrect": true,
        "rationale": "Correct. The ECG shows clear evidence of hyperkalemic cardiotoxicity (widened QRS, peaked T-waves). These ECG changes indicate impaired cardiac conduction and increased risk of ventricular dysrhythmias, such as ventricular tachycardia or fibrillation, which can lead to cardiac arrest. Continuous cardiac monitoring is an essential, immediate safety intervention to detect any lethal arrhythmias and allow for prompt intervention. The nurse should closely observe the ECG for changes in QRS width, T-wave morphology, and the presence of arrhythmias."
      },
      "act_5": {
        "isCorrect": false,
        "rationale": "Incorrect. This action is dangerous and directly contraindicated. Proceeding with a contrast-enhanced CT would expose the already injured kidneys to a nephrotoxic agent, worsening the AKI. Furthermore, it delays the urgent treatment required for the life-threatening hyperkalemia. This action could have severe consequences for the client's renal function and overall prognosis."
      }
    },
    "monitoring": {
      "mon_1": {
        "isCorrect": false,
        "rationale": "Incorrect. While urine output is an important indicator of kidney function, it is not the most direct parameter to monitor for the immediate life-threatening complication of hyperkalemia. Specific gravity is even less relevant for assessing the acute cardiac risk. The focus should be on parameters that reflect the cardiac effects of hyperkalemia and the effectiveness of potassium-lowering treatments."
      },
      "mon_2": {
        "isCorrect": true,
        "rationale": "Correct. The ECG provides a real-time assessment of the physiological effect of potassium on the cardiac cells. Improvement in the QRS width and normalization of the T-waves are the most immediate indicators that treatments to lower serum potassium (e.g., calcium gluconate, insulin/dextrose) are effectively stabilizing the myocardium. The nurse should continuously monitor the ECG for changes that indicate worsening or improving hyperkalemia."
      },
      "mon_3": {
        "isCorrect": true,
        "rationale": "Correct. Since severe hyperkalemia is the life-threatening condition, monitoring the serum potassium level is essential to evaluate the effectiveness of interventions. The goal is to see a rapid decrease in the potassium level back toward a safe range (3.5-5.0 mEq/L). Serial potassium measurements should be obtained to track the response to treatment and guide further interventions."
      },
      "mon_4": {
        "isCorrect": false,
        "rationale": "Incorrect. BUN is a marker for uremia and kidney function, but it changes relatively slowly and does not reflect the acute, minute-to-minute cardiac risk posed by hyperkalemia. Monitoring BUN is important for the overall management of AKI, but not for the immediate emergency. The priority is to monitor parameters that directly reflect the cardiac effects of hyperkalemia."
      },
      "mon_5": {
        "isCorrect": false,
        "rationale": "Incorrect. While the client's respiratory status is worsening, likely due to fluid overload, this is a secondary complication. The most immediate threat to life is cardiac arrest from hyperkalemia. Therefore, monitoring parameters directly related to potassium and its cardiac effects is the highest priority. Respiratory rate and oxygen saturation are important to monitor, but not as critical as ECG changes and potassium levels in this situation."
      }
    }
  },
  "cognitiveSkill": "Analyze",
  "clientNeed": "Physiological Adaptation",
  "contentArea": "Renal",
  "priorityConcept": "Acid-Base Balance",
  "alternateItemFormats": [],
  "integratedProcesses": [
    "Nursing Process",
    "Clinical Judgment"
  ],
  "sbar": {
    "situation": "1200: 58-year-old male admitted for community-acquired pneumonia, scheduled for CT Angiography with IV contrast to rule out pulmonary embolism.",
    "background": "History of poorly controlled type 2 diabetes and hypertension. Increasing fatigue and mild shortness of breath. Lungs with fine crackles in bilateral bases. Urine output decreased to 150mL from 2300-0700. Labs show elevated BUN (52 mg/dL) and creatinine (3.1 mg/dL), and hyperkalemia (6.2 mEq/L). ECG shows peaked T-waves and widened QRS. Lisinopril held since admission.",
    "assessment": "Acute Kidney Injury with severe hyperkalemia, posing a risk for cardiac dysrhythmias. Contraindication for CT Angiography with IV contrast due to AKI.",
    "recommendation": "Withhold contrast media and notify the provider immediately. Place the client on continuous cardiac monitoring. Monitor ECG morphology and serum potassium level every 1-2 hours. Anticipate orders for treatment of hyperkalemia, such as calcium gluconate, insulin/dextrose, or sodium polystyrene sulfonate. Consider alternative imaging without contrast."
  },
  "clinicalPearl": "In patients with AKI, especially those with diabetes, avoid nephrotoxic agents like IV contrast to prevent contrast-induced nephropathy. Hyperkalemia can cause life-threatening arrhythmias; prompt recognition and treatment are crucial. ECG changes (peaked T-waves, widened QRS) are early indicators of hyperkalemia's effect on the heart. Monitor urine output closely in AKI patients, but prioritize interventions that address the immediate threat of hyperkalemia.",
  "keywords": [
    "Acute Kidney Injury",
    "Hyperkalemia",
    "Contrast-Induced Nephropathy",
    "ECG Changes",
    "Electrolyte Imbalance",
    "Renal Failure",
    "Patient Safety"
  ],
  "sentinelStatus": "healed_v2026_v8"
}